Treatment Toxicity: Radiation

  • T. J. FitzGerald
  • Maryann Bishop-Jodoin
  • Fran Laurie
  • Allison Sacher
  • Richard V. Aghababian
  • Eric Dickson
Chapter
First Online:

Abstract

Intentional and unintentional radiation exposures have a powerful impact on normal tissue function and can induce both short-term and long-term injury to all cell systems. Radiation effects can last a lifetime for a patient and can produce complications for all organ systems. Primary care and emergency medicine health-care providers should understand acute and late effects of radiation treatment and exposure and how these interrelate with patient acute health care. Access to patients’ entire medical record portfolios as well as communication strategies with radiation experts needs to be available. The management of radiation’s acute and late effects in adults and pediatrics is presented.

Keywords

Radiation Exposure Dose Volume Cell damage Toxicity Injury Treatment Patients Cancer 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott, Williams and Wilkins; 2012.Google Scholar
  2. 2.
    Miller D, Balter S, Cole P, Lu H, Berenstein A, Albert R, et al. Radiation doses in interventional radiology procedures: the RAD-IR study: part II: skin dose. J Vasc Interv Radiol. 2003;14(8):977–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Miller D, Balter S, Wagner L, Cardella J, Clark T, Neithamer CJ, et al. Quality improvement guidelines for recording patient radiation dose in the medical record. J Vasc Interv Radiol. 2004;15(5):423–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Shope T. Radiation-induced skin injuries from fluoroscopy [Internet]. U.S. Food and Drug Administration. 1996 [cited 2014 Jun 19]. Available from: http://www.fda.gov/radiation-emittingproducts/radiationemittingproductsandprocedures/medicalimaging/medicalx-rays/ucm116682.htm
  5. 5.
    Donnelly E, Nemhauser J, Smith J, Kazzi Z, Farfán E, Chang A, et al. Acute radiation syndrome: assessment and management. South Med J. 2010;103(6):541–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Turai I, Veress K. Radiation accidents: occurrence, types, consequences, medical management, and lessons learned. Central Eur J Occup Environ Med. 2001;7(1):3–14.Google Scholar
  7. 7.
    Baranov A, Gale R, Guskova A, Piatkin E, Selidovkin G, Muravyova L, et al. Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med. 1989;321(4):205–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Wikipedia Contributors. Acute radiation syndrome [Internet]. Wikipedia, The Free Encyclopedia. 2014 [cited 2014 Jun 18]. Available from: http://en.wikipedia.org/w/index.php?title=Acute_radiation_syndrome&oldid=608982279
  9. 9.
    Fitzgerald T, Jodoin M, Tillman G, Aronowitz J, Pieters R, Balducci S, et al. Radiation therapy toxicity to the skin. Dermatol Clin. 2008;26(1):161–72.CrossRefPubMedGoogle Scholar
  10. 10.
    Citrin D, Cotrim A, Hyodo F, Baum B, Krishna M, Mitchell J. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 2010;15(4):360–71.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Patt H, Tyree E, Straube R, Smith D. Cysteine protection against X irradiation. Science. 1949;110(2852):213–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Brizel D, Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol. 2003;4(6):378–81.CrossRefPubMedGoogle Scholar
  13. 13.
    Brizel D, Wasserman T, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000;18(19):3339–45.PubMedGoogle Scholar
  14. 14.
    Chitra S, Shyamala DC. Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer. Indian J Dent Res. 2008;19(3):213–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Bentzen S. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6(9):702–13.CrossRefPubMedGoogle Scholar
  16. 16.
    Epperly M, Bray J, Krager S, Berry L, Gooding W, Engelhardt J, et al. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys. 1999;43(1):169–81.CrossRefPubMedGoogle Scholar
  17. 17.
    Epperly M, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger J. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther. 2000;7(12):1011–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Farrell C, Rex K, Kaufman S, Dipalma C, Chen J, Scully S, et al. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol. 1999;75(5):609–20.CrossRefPubMedGoogle Scholar
  19. 19.
    Soule B, Hyodo F, Matsumoto K, Simone N, Cook J, Krishna M, et al. Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal. 2007;9(10):1731–43.CrossRefPubMedGoogle Scholar
  20. 20.
    Hyodo F, Matsumoto K, Matsumoto A, Mitchell J, Krishna M. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res. 2006;66(20):9921–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Guo H, Seixas-Silva JJ, Epperly M, Gretton J, Shin D, Bar-Sagi D, et al. Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene. Radiat Res. 2003;159(3):361–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Stickle R, Epperly M, Klein E, Bray J, Greenberger J. Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. Radiat Oncol Investig. 1999;7(4):204–17.CrossRefPubMedGoogle Scholar
  23. 23.
    Burdelya L, Krivokrysenko V, Tallant T, Strom E, Gleiberman A, Gupta D, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 2008;320(5873):226–30.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Anscher M, Thrasher B, Rabbani Z, Teicher B, Vujaskovic Z. Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys. 2006;65(3):876–81.CrossRefPubMedGoogle Scholar
  25. 25.
    Anscher M, Thrasher B, Zgonjanin L, Rabbani Z, Corbley M, Fu K, et al. Small molecule inhibitor of transforming growth factor-β protects against development of radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2008;71(3):829–37.CrossRefPubMedGoogle Scholar
  26. 26.
    Massagué J. TGFbeta in cancer. Cell. 2008;134(2):215–30.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Chin M, Freniere B, Bonney C, Lancerotto L, Saleeby J, Lo Y, et al. Skin perfusion and oxygenation changes in radiation fibrosis. Plast Reconstr Surg. 2013;131(4):707–16.CrossRefPubMedGoogle Scholar
  28. 28.
    Chin M, Freniere B, Lo Y, Saleeby J, Baker S, Strom H, et al. Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin. J Biomed Opt. 2012;17(2):026010.CrossRefPubMedGoogle Scholar
  29. 29.
    Fajardo L, Berthrong M, Anderson R. Radiation pathology. 1st ed. New York: Oxford University Press; 2001.Google Scholar
  30. 30.
    Majno G, Joris I. Cells, tissues, and disease: principles of general pathology. 2nd ed. New York: Oxford University Press; 2004.Google Scholar
  31. 31.
    Hoppe B, Laser B, Kowalski A, Fontenla S, Pena-Greenberg E, Yorke E, et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys. 2008;72(5):1283–6.CrossRefPubMedGoogle Scholar
  32. 32.
    FitzGerald T, Aronowitz J, Giulia Cicchetti M, Fisher G, Kadish S, Lo Y, et al. The effect of radiation therapy on normal tissue function. Hematol Oncol Clin North Am. 2006;20(1):141–63.CrossRefPubMedGoogle Scholar
  33. 33.
    Moulder J, Cohen E. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol. 2007;17(2):141–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Quantitative analyses of normal tissue effects in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(Suppl 3):S1–160.Google Scholar
  35. 35.
    McCulloch T, Jaffe D. Head and neck disorders affecting swallowing. GI Motility. 2006. doi: 10.1038/gimo36.Google Scholar
  36. 36.
    Guha C, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol. 2011;21(4):256–63.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Sioshansi S, Rava PS, Karam AR, Lithgow M, Ding L, Xing W, et al. Diaphragm injury after liver stereotactic body radiation therapy. Pract Radiat Oncol. 2014;4(6):e227–30.CrossRefPubMedGoogle Scholar
  38. 38.
    Merrill W. Radiation-induced lung injury. In: Kavanaugh B, Hollingsworth H, editors. UpToDate. Waltham: UpToDate; 2014.Google Scholar
  39. 39.
    Sugihara T, Hattori Y, Yamamoto Y, Qi F, Ichikawa R, Sato A, et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation. 1999;100(6):635–41.CrossRefPubMedGoogle Scholar
  40. 40.
    Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218–27.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Evans SB, Sioshansi S, Moran MS, Hiatt J, Price LL, Wazer DE. Prevalence of poor cardiac anatomy in carcinoma of the breast treated with whole-breast radiotherapy: reconciling modern cardiac dosimetry with cardiac mortality data. Am J Clin Oncol. 2012;35(6):587–92.CrossRefPubMedGoogle Scholar
  42. 42.
    Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol. 2012;30(30):3657–64.CrossRefPubMedGoogle Scholar
  43. 43.
    Marks LB, Yu X, Prosnitz RG, Zhou S-M, Hardenbergh PH, Blazing M, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63(1):214–23.CrossRefPubMedGoogle Scholar
  44. 44.
    Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol. 2002;20(8):2101–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206–14.CrossRefPubMedGoogle Scholar
  47. 47.
    Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Klijn JGM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365–75.CrossRefPubMedGoogle Scholar
  48. 48.
    Weintraub NL, Jones WK, Manka D. Understanding radiation-induced vascular disease. J Am Coll Cardiol. 2010;55(12):1237–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Lipshultz SE, Sallan SE. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol. 1993;11(7):1199–203.PubMedGoogle Scholar
  50. 50.
    Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, et al. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med. 2006;47(11):1756–62.PubMedGoogle Scholar
  51. 51.
    Lam WW, Leung SF, So NM, Wong KS, Liu KH, Ku PK, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92(9):2357–63.CrossRefPubMedGoogle Scholar
  52. 52.
    Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45(1):55–75.CrossRefPubMedGoogle Scholar
  53. 53.
    Katz NM, Hall AW, Cerqueira MD. Radiation induced valvulitis with late leaflet rupture. Heart. 2001;86(6), E20.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Slama MS, Le Guludec D, Sebag C, Leenhardt AR, Davy JM, Pellerin DE, et al. Complete atrioventricular block following mediastinal irradiation: a report of six cases. Pacing Clin Electrophysiol. 1991;14(7):1112–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Pieters RS, Niemierko A, Fullerton BC, Munzenrider JE. Cauda equina tolerance to high-dose fractionated irradiation. Int J Radiat Oncol Biol Phys. 2006;64(1):251–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Giese W, Kinsella T. Radiation injury to peripheral and cranial nerves. In: Gutin P, Leibel S, Sheline G, editors. Radiation injury to the nervous system. New York: Raven; 1991. p. 383–403.Google Scholar
  57. 57.
    Harris JR, Levine MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976;120(1):167–71.CrossRefPubMedGoogle Scholar
  58. 58.
    Stoll BA, Andrews JT. Radiation-induced peripheral neuropathy. Br Med J. 1966;1(5491):834–7.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Powell S, Cooke J, Parsons C. Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol. 1990;18(3):213–20.CrossRefPubMedGoogle Scholar
  60. 60.
    World Nuclear Association. Radiation|Nuclear Radiation|Ionizing Radiation|Health Effects [Internet]. 2014 [cited 2014 Aug 28]. Available from: http://www.world-nuclear.org/info/Safety-and-Security/Radiation-and-Health/Nuclear-Radiation-and-Health-Effects/
  61. 61.
    Niazi AK, Niazi SK. Endocrine effects of Fukushima: radiation-induced endocrinopathy. Indian J Endocrinol Metab. 2011;15(2):91–5.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol. 2003;41(3):208–11.CrossRefPubMedGoogle Scholar
  63. 63.
    Ding L, Kadish S, Goff D, Pieters RS, Graeber G, Uy K, et al. Volume modulated arc therapy (VMAT) for pulmonary stereotactic body radiotherapy (SBRT) in patients with lesions in close approximation to the chest wall. Front Oncol. 2013;3:12.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • T. J. FitzGerald
    • 1
  • Maryann Bishop-Jodoin
    • 2
  • Fran Laurie
    • 2
  • Allison Sacher
    • 1
  • Richard V. Aghababian
  • Eric Dickson
    • 3
  1. 1.Department of Radiation OncologyUniversity of Massachusetts Medical School/UMass Memorial Health CareWorcesterUSA
  2. 2.Department of Radiation OncologyUniversity of Massachusetts Medical SchoolWorcesterUSA
  3. 3.Department of Emergency MedicineUniversity of Massachusetts Medical School/UMass Memorial Health CareWorcesterUSA

Personalised recommendations